Skip to main content
TipRanks
Go Ultimate75% OFF

TuHURA Biosciences (HURA) Financial Statements

1,029 Followers

TuHURA Biosciences Financial Overview

TuHURA Biosciences's market cap is currently $88.58M. The company's EPS TTM is $-0.50; its P/E ratio is -2.78; TuHURA Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Jun 23Jun 22Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ -55.00K$ -60.00K$ -60.00K
Operating Income$ -31.80M$ -17.65M$ -8.45M$ -14.80M$ -22.68M
EBITDA$ -29.36M$ -17.43M$ -8.14M$ -14.28M$ -21.65M
Net Income$ -30.06M$ -21.68M$ -8.32M$ -14.65M$ -22.66M
Balance Sheet
Cash & Short-Term Investments$ 3.62M$ 12.66M$ 3.67M$ 14.25M$ 5.55M
Total Assets$ 27.35M$ 19.97M$ 4.36M$ 15.20M$ 6.40M
Total Debt$ 700.02K$ 202.54K$ 2.34M$ 138.22K$ 644.07K
Net Debt$ -2.92M$ -12.45M$ -1.32M$ -14.11M$ -4.90M
Total Liabilities$ 6.42M$ 5.37M$ 5.92M$ 2.89M$ 7.15M
Stockholders' Equity$ 20.93M$ 14.59M$ -1.56M$ 12.30M$ -747.82K
Cash Flow
Free Cash Flow$ -27.71M$ -14.79M$ -12.03M$ -7.54M$ -6.57M
Operating Cash Flow$ -27.63M$ -14.73M$ -11.95M$ -7.51M$ -6.56M
Investing Cash Flow$ -1.34M$ -6.05M$ -1.30M$ -36.28K$ -3.28K
Financing Cash Flow$ 19.93M$ 29.77M$ 2.66M$ 16.25M$ 7.04M

Currency in USD

TuHURA Biosciences Earnings and Revenue History

-45M-30M-15M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

TuHURA Biosciences Liabilities to Assets

010M20M30M0 %50 %100 %150 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

TuHURA Biosciences Cash Flow

-40M-30M-20M-10M010M20M30M40M201720182019202020212022202320242025OperatingInvestingFinancing

TuHURA Biosciences Forecast EPS vs Actual EPS

-0.2-0.1-0.1-0.1-0.1Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss